Quality of postoperative venous thromboembolism prophylaxis in neuro-oncologic surgery

Neurosurgery

Volumn 80, Issue 1, 2017, Pages 73-81

  Zacharia, Brad E ^a   Youngerman, Brett E ^b   Bruce, Samuel S ^b   Hershman, Dawn L ^c   Neugut, Alfred I ^c   Bruce, Jeffrey N ^b   Wright, Jason D ^d  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b Department of Medicine   (United States)

^c Department of Medicine   (United States)

^d NONE   (United States)

Author keywords

Brain tumor; Deep venous thrombosis; Prophylaxis; Pulmonary embolism; Quality; Venous thromboembolism

Indexed keywords

DALTEPARIN; ENOXAPARIN; FONDAPARINUX; TINZAPARIN; ANTICOAGULANT AGENT;

ACOUSTIC NEUROMA; ADULT; ARTICLE; BRAIN BIOPSY; BRAIN METASTASIS; BRAIN TUMOR; CANCER PATIENT; EMERGENCY CARE; FEMALE; HIGH VOLUME HOSPITAL; HIGH VOLUME SURGEON; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; ICD-10; MAJOR CLINICAL STUDY; MALE; MEDICAID; MENINGIOMA; METASTATIC BRAIN LESION; MIDDLE AGED; NEUROSURGERY; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURGEON VOLUME; SURGICAL ONCOLOGY; THROMBOSIS PREVENTION; UNITED STATES; VENOUS THROMBOEMBOLISM; AGED; BRAIN NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGED; ANTICOAGULANTS; BRAIN NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES; VENOUS THROMBOEMBOLISM;

EID: 84973327563     PISSN: 0148396X     EISSN: 15244040     Source Type: Journal    
DOI: 10.1227/NEU.0000000000001270     Document Type: Article

References (69)

1. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest. 2001;119(suppl 1):132S-175S.
2. Amin AN, Stemkowski S, Lin J, Yang G. Inpatient thromboprophylaxis use in U.S. hospitals: adherence to the seventh American College of Chest Physician’s recommendations for at-risk medical and surgical patients. J Hosp Med. 2009;4(8): E15-E21. doi:10.1002/jhm.526.
3. Wright JD, Hershman DL, Shah M, et al. Quality of perioperative venous thromboembolism prophylaxis in gynecologic surgery. Obstet Gynecol. 2011;118 (5):978-986. doi:10.1097/AOG.0b013e31822c952a.
4. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(suppl 6):381S-453S. doi:10.1378/chest.08-0656.
5. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ, III. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000;160(6):809-815.
6. Blom JW, Doggen CJM, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005;293(6):715-722. doi: 10.1001/jama.293.6.715.
7. Hillen HF. Thrombosis in cancer patients. Ann Oncol. 2000;11(suppl 3): 273-276.
8. Gerber DE, Grossman SA, Streiff MB. Management of venous thromboembolism in patients with primary and metastatic brain tumors. J Clin Oncol. 2006;24(8): 1310-1318. doi:10.1200/JCO.2005.04.6656.
9. Amin AN, Lin J, Yang G, Stemkowski S. Are there any differences in the clinical and economic outcomes between US cancer patients receiving appropriate or inappropriate venous thromboembolism prophylaxis? J Oncol Pract. 2009;5(4): 159-164. doi:10.1200/JOP.0942002.
10. Kakkar AK, Williamson RC. Prevention of venous thromboembolism in cancer patients. Semin Thromb Hemost. 1999;25(2):239-243. doi:10.1055/s-2007-994925.
11. White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost. 2003;90(3):446-455. doi:10.1267/THRO03030446.
12. Dickinson LD, Miller LD, Patel CP, Gupta SK. Enoxaparin increases the incidence of postoperative intracranial hemorrhage when initiated preoperatively for deep venous thrombosis prophylaxis in patients with brain tumors. Neurosurgery. 1998;43(5):1074-1081.
13. Goldhaber SZ, Dunn K, Gerhard-Herman M, Park JK, Black PM. Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis. Chest. 2002;122(6):1933-1937.
14. Agnelli G, Piovella F, Buoncristiani P, et al. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med. 1998;339(2):80-85. doi:10.1056/NEJM199807093390204.
15. Auguste KI, Quiñones-Hinojosa A, Berger MS. Efficacy of mechanical prophylaxis for venous thromboembolism in patients with brain tumors. Neurosurg Focus. 2004;17(4):E3.
16. Brandes AA, Scelzi E, Salmistraro G, et al. Incidence of risk of thromboembolism during treatment high-grade gliomas: a prospective study. Eur J Cancer. 1997;33 (10):1592-1596.
17. Zacharia BE, Deibert C, Gupta G, et al. Incidence, cost, and mortality associated with hospital-acquired conditions following resection of cranial neoplasms. Neurosurgery. 2014;74(6):638-647. doi:10.1227/NEU.0000000000000342.
18. Eisenring CV, Neidert MC, Sabanés Bové D, Held L, Sarnthein J, Krayenbühl N. Reduction of thromboembolic events in meningioma surgery: a cohort study of 724 consecutive patients. PLoS One. 2013;8(11):e79170. doi:10.1371/journal.pone.0079170.
19. Cage TA, Lamborn KR, Ware ML, et al. Adjuvant enoxaparin therapy may decrease the incidence of postoperative thrombotic events though does not increase the incidence of postoperative intracranial hemorrhage in patients with menin-giomas. J Neurooncol. 2009;93(1):151-156. doi:10.1007/s11060-009-9886-4.
20. Whittle IR, Smith C, Navoo P, Collie D. Meningiomas. Lancet. 2004;363(9420): 1535-1543. doi:10.1016/S0140-6736(04)16153-9.
21. Cerrato D, Ariano C, Fiacchino F. Deep vein thrombosis and low-dose heparin prophylaxis in neurosurgical patients. J Neurosurg. 1978;49(3):378-381. doi:10.3171/jns.1978.49.3.0378.
22. Salmaggi A, Simonetti G, Trevisan E, et al. Perioperative thromboprophylaxis in patients with craniotomy for brain tumours: a systematic review. J Neurooncol. 2013;113(2):293-303. doi:10.1007/s11060-013-1115-5.
23. Donati MB. Cancer and thrombosis. Haemostasis. 1994;24(2):128-131.
24. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(suppl 3):338S-400S. doi:10.1378/chest.126.3_suppl.338S.
25. Kuderer NM, Khorana AA, Lyman GH, Francis CW. A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications. Cancer. 2007;110(5):1149-1161. doi:10.1002/cncr.22892.
26. Amin A, Stemkowski S, Lin J, Yang G. Thromboprophylaxis rates in US medical centers: success or failure? J Thromb Haemost. 2007;5(8):1610-1616. doi:10.1111/j.1538-7836.2007.02650.x.
27. Treasure T, Hill J. NICE guidance on reducing the risk of venous thromboembolism in patients admitted to hospital. J R Soc Med. 2010;103(6):210-212. doi: 10.1258/jrsm.2010.100086.
28. Guyatt GH, Norris SL, Schulman S, et al. Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(suppl 2): 53S-70S. doi:10.1378/chest.11-2288.
29. Amin AN, Stemkowski S, Lin J, Yang G. Preventing venous thromboembolism in US hospitals: are surgical patients receiving appropriate prophylaxis? Thromb Haemost. 2008;99(4):796-797. doi:10.1160/TH07-11-0708.
30. Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371(9610):387-394. doi:10.1016/S0140-6736(08)60202-0.
31. Kakkar AK, Cohen AT, Tapson VF, et al. Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients. Ann Surg. 2010;251(2):330-338. doi:10.1097/SLA.0b013e3181c0e58f.
32. Yu HT, Dylan ML, Lin J, Dubois RW. Hospitals’ compliance with prophylaxis guidelines for venous thromboembolism. Am J Health Syst Pharm. 2007;64(1):69-76. doi:10.2146/ajhp060115.
33. Wright JD, Lewin SN, Shah M, et al. Quality of venous thromboembolism prophylaxis in patients undergoing oncologic surgery. Ann Surg. 2011;253(6): 1140-1146. doi:10.1097/SLA.0b013e31821287ac.
34. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
35. Hojsgaard S, Halekoh U, Yan J. The R package geepack for generalized estimating equations. J Stat Softw. 2006;15(2):1-11.
36. Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(suppl 2):e227S-e277S. doi:10.1378/chest.11-2297.
37. Constantini S, Kanner A, Friedman A, et al. Safety of perioperative minidose heparin in patients undergoing brain tumor surgery: a prospective, randomized, double-blind study. J Neurosurg. 2001;94(6):918-921. doi:10.3171/jns.2001.94.6.0918.
38. Macdonald RL, Amidei C, Baron J, et al. Randomized, pilot study of intermittent pneumatic compression devices plus dalteparin versus intermittent pneumatic compression devices plus heparin for prevention of venous thromboembolism in patients undergoing craniotomy. Surg Neurol. 2003;59(5):363-372; discussion 372-374.
39. Nurmohamed MT, van Riel AM, Henkens CM, et al. Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery. Thromb Haemost. 1996;75(2):233-238.
40. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O’Fallon WM, Melton LJ, III. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med. 2000;160(6):761-768.
41. Kakkar AK, Haas S, Wolf H, Encke A. Evaluation of perioperative fatal pulmonary embolism and death in cancer surgical patients: the MC-4 cancer substudy. Thromb Haemost. 2005;94(4):867-871. doi:10.1160/TH04-03-0189.
42. Simanek R, Vormittag R, Hassler M, et al. Venous thromboembolism and survival in patients with high-grade glioma. Neuro Oncol. 2007;9(2):89-95. doi:10.1215/15228517-2006-035.
43. Agnelli G, Verso M. Thromboprophylaxis during chemotherapy after advanced cancer. Thromb Res. 2007;120(suppl 2):S128-S132. doi:10.1016/S0049-3848(07)70141-X.
44. Marras LC, Geerts WH, Perry JR. The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review. Cancer. 2000;89(3):640-646.
45. Amin A, Stemkowski S, Lin J, Yang G. Appropriate thromboprophylaxis in hospitalized cancer patients. Clin Adv Hematol Oncol. 2008;6(12): 910-920.
46. Deitelzweig SB, Lin J, Hussein M, Battleman D. Are surgical patients at risk of venous thromboembolism currently meeting the Surgical Care Improvement Project performance measure for appropriate and timely prophylaxis? J Thromb Thrombolysis. 2010;30(1):55-66. doi:10.1007/s11239-009-0393-4.
47. Kahn SR, Panju A, Geerts W, et al. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada. Thromb Res. 2007;119(2):145-155. doi:10.1016/j.thromres.2006.01.011.
48. Bilimoria KY, Phillips JD, Rock CE, Hayman A, Prystowsky JB, Bentrem DJ. Effect of surgeon training, specialization, and experience on outcomes for cancer surgery: a systematic review of the literature. Ann Surg Oncol. 2009;16(7):1799-1808. doi:10.1245/s10434-009-0467-8.
49. Birkmeyer JD, Reames BN, McCulloch P, Carr AJ, Campbell WB, Wennberg JE. Understanding of regional variation in the use of surgery. Lancet. 2013;382(9898): 1121-1129. doi:10.1016/S0140-6736(13)61215-5.
50. Tsai TC, Joynt KE, Orav EJ, Gawande AA, Jha AK. Variation in surgical-readmission rates and quality of hospital care. N Engl J Med. 2013;369(12):1134-1142. doi:10.1056/NEJMsa1303118.
51. Long DM, Gordon T, Bowman H, et al. Outcome and cost of craniotomy performed to treat tumors in regional academic referral centers. Neurosurgery. 2003;52(5):1056-1063; discussion 1063-1065.
52. Zacharia BE, Ducruet AF, Hickman ZL, et al. Technological advances in the management of unruptured intracranial aneurysms fail to improve outcome in New York state. Stroke. 2011;42(10):2844-2849. doi:10.1161/STROKEAHA. 111.619767.
53. Cowan JA, Dimick JB, Leveque JC, Thompson BG, Upchurch GR, Hoff JT. The impact of provider volume on mortality after intracranial tumor resection. Neurosurgery. 2003;52(1):48-53; discussion 53-54.
54. Nuño M, Mukherjee D, Carico C, et al. The effect of centralization of caseload for primary brain tumor surgeries: trends from 2001-2007. Acta Neurochir (Wien). 2012;154(8):1343-1350. doi:10.1007/s00701-012-1358-5.
55. Barker FG, Curry WT, Carter BS. Surgery for primary supraten-torial brain tumors in the United States, 1988 to 2000: the effect of provider caseload and centralization of care. Neuro Oncol. 2005;7(1):49-63. doi:10.1215/S1152851704000146.
56. Barker FG, II. Craniotomy for the resection of metastatic brain tumors in the U.S., 1988-2000: decreasing mortality and the effect of provider caseload. Cancer. 2004; 100(5):999-1007. doi:10.1002/cncr.20058.
57. Ambekar S, Sharma M, Madhugiri VS, Nanda A. Trends in intracranial meningioma surgery and outcome: a Nationwide Inpatient Sample database analysis from 2001 to 2010. J Neurooncol. 2013;114(3):299-307. doi:10.1007/s11060-013-1183-6.
58. Zacharia BE, Bruce SS, Carpenter AM, et al. Variability in outcome after elective cerebral aneurysm repair in high-volume academic medical centers. Stroke. 2014; 45(5):1447-1452. doi:10.1161/STROKEAHA.113.004412.
59. Auerbach AD, Hilton JF, Maselli J, Pekow PS, Rothberg MB, Lindenauer PK. Shop for quality or volume? Volume, quality, and outcomes of coronary artery bypass surgery. Ann Intern Med. 2009;150(10):696-704.
60. Birkmeyer JD, Sun Y, Goldfaden A, Birkmeyer NJO, Stukel TA. Volume and process of care in high-risk cancer surgery. Cancer. 2006;106(11):2476-2481. doi: 10.1002/cncr.21888.
61. Birkmeyer JD, Siewers AE, Finlayson EVA, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346(15):1128-1137. doi:10.1056/NEJMsa012337.
62. Cupitt JM. Prophylaxis against thromboembolism in patients with traumatic brain injury: a survey of UK practice. Anaesthesia. 2001;56(8):780-785.
63. Guidry U, McLaren Black P, Goldhaber SZ. Venous thromboembolism prophylaxis in the craniotomy patient: an editorial. Surg Neurol. 1998;50(2): 182-183.
64. Kleindienst A, Harvey HB, Mater E, et al. Early antithrombotic prophylaxis with low molecular weight heparin in neurosurgery. Acta Neurochir (Wien). 2003;145 (12):1085-1090; discussion 1090-1091. doi:10.1007/s00701-003-0142-y.
65. Gerlach R, Scheuer T, Beck J, Woszczyk A, Seifert V, Raabe A. Risk of postoperative hemorrhage after intracranial surgery after early nadroparin administration: results of a prospective study. Neurosurgery. 2003;53(5):1028-1034; discussion 1034-1035.
66. Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med. 2005;352(10): 969-977. doi:10.1056/NEJMoa041533.
67. Tooher R, Middleton P, Pham C, et al. A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals. Ann Surg. 2005;241(3):397-415.
68. Lindenauer PK, Pekow P, Gao S, Crawford AS, Gutierrez B, Benjamin EM. Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2006;144(12):894-903.
69. Bockheim HM, McAllen KJ, Baker R, Barletta JF. Mechanical prophylaxis to prevent venous thromboembolism in surgical patients: a prospective trial evaluating compliance. J Crit Care. 2009;24(2):192-196. doi:10.1016/j.jcrc.2009.01.001.